Abstract

Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations

Author(s): Trissel Lawrence A

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases

Page(s): 524-528

Download in electronic PDF format for $75
  • Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Page 1
  • Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Page 2
  • Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Page 3
  • Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Page 4
  • Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Page 5

Abstract

United States Pharmacopeia Chapter <797> provides guidelines and standards that deal with the preparation, compounding, and labeling of compounded sterile preparations. These standards ensure patient care and safety by defining safe practice. The Chapter gives instructions on determining beyond-use dates for the different risk categories associated with compounded preparations. Each of these categories has specific aspects of environmental, personnel, and situational deterrents that Chapter <797> requires to be taken into account. By following the standards of Chapter <797>, compounding pharmacists can alleviate danger to the patient and themselves in any situation.

Related Keywords

  • United States Pharmacopeia
  • Chapter <797>
  • compounded sterile preparations
  • beyond use dating
  • quality control
  • standards
  • drug storage
  • sterility
  • drug stability
  • microbiological contamination risk category
  • risk level

Related Categories

  • STABILITIES, COMPATIBILITIES
  • STERILE PREPARATIONS
  • QUALITY CONTROL
  • UNITED STATES PHARMACOPEIA CONVENTIONS
  • STORAGE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2008
Pg. 524-528
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Author(s): Trissel Lawrence A
May/Jun 2010
Pg. 232-238
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2008
Pg. 344-353
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2005
Pg. 136-138
Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations
Author(s): Kupiec Thomas C
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
Sep/Oct 2007
Pg. 400-403
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Author(s): Kupiec Thomas C
Jul/Aug 2018
Pg. 303-312
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Author(s): Martin Matt
Mar/Apr 2020
Pg. 92
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 307-311
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
Author(s): McElhiney Linda F
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
Jul/Aug 2007
Pg. 302-305
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Author(s): Okeke Claudia C
Jan/Feb 2005
Pg. 47-49
Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations
Author(s): Kupiec Thomas C
Sep/Oct 2007
Pg. 404-410
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2021
Pg. 115-124
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
May/Jun 2009
Pg. 234-238
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control
Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2008
Pg. 136-144
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2012
Pg. 471-474
Beyond-use Date: Establishment and Maintenance
Author(s): Osteen Richard
May/Jun 2020
Pg. 180
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 383-386
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Author(s): Donnelly Ronald F
Jul/Aug 2006
Pg. 281-284
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist
Author(s): Zolner William J